{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:12:35Z","timestamp":1790190755578,"version":"4.1.0"},"reference-count":478,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institute of Myology"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jaut.2014.05.001","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T14:00:36Z","timestamp":1402668036000},"page":"1-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"special_numbering":"C","title":["Myasthenia Gravis: Paradox versus paradigm in autoimmunity"],"prefix":"10.1016","volume":"52","author":[{"given":"Sonia","family":"Berrih-Aknin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2014.05.001_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaut.2012.10.004","article-title":"Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis","volume":"41","author":"Wang","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaut.2012.09.002","article-title":"Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review","volume":"39","author":"Ngalamika","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/003693306000501001","article-title":"Myasthenia gravis: a new hypothesis","volume":"5","author":"Simpson","year":"1960","journal-title":"Scott Med J"},{"key":"10.1016\/j.jaut.2014.05.001_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.182.4109.293","article-title":"Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors","volume":"182","author":"Fambrough","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jaut.2014.05.001_bib5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jaut.2014.05.001_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.1179220","article-title":"Myasthenia gravis: passive transfer from man to mouse","volume":"190","author":"Toyka","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.jaut.2014.05.001_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.410090609","article-title":"Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects","volume":"9","author":"Burres","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0140-6736(75)92779-8","article-title":"Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis","volume":"2","author":"Aharonov","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2014.05.001_bib9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.001_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A\u00a0comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaut.2012.05.007","article-title":"Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop","volume":"39","author":"Selmi","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jaut.2012.05.020","article-title":"Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop","volume":"39","author":"Germolec","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jaut.2012.05.002","article-title":"Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop","volume":"39","author":"Miller","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia gravis","volume":"48\u201349","author":"Berrih-Aknin","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib17","doi-asserted-by":"crossref","first-page":"J156","DOI":"10.1016\/j.jaut.2011.11.003","article-title":"Twin studies in autoimmune disease: genetics, gender and environment","volume":"38","author":"Bogdanos","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2010.03.016","article-title":"Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis","volume":"32","author":"Husebye","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2014.05.001_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaut.2012.11.004","article-title":"AIRE expressing marginal zone dendritic cells balances adaptive immunity and T-follicular helper cell recruitment","volume":"42","author":"Lindmark","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaut.2012.12.004","article-title":"FOXP3: genetic and epigenetic implications for autoimmunity","volume":"41","author":"Katoh","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/smim.1998.0155","article-title":"Fas\/APO-1\/CD95 in health and autoimmune disease: thymic and peripheral aspects","volume":"10","author":"Moulian","year":"1998","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib22","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2013-10-535393","article-title":"Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations","volume":"123","author":"Price","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2014.05.001_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jaut.2012.05.018","article-title":"Low levels of vitamin-D are associated with neuropathy and lymphoma\u00a0among patients with Sjogren's syndrome","volume":"39","author":"Agmon-Levin","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib24","doi-asserted-by":"crossref","first-page":"J71","DOI":"10.1016\/j.jaut.2011.12.007","article-title":"Sex gender and autoimmunity","volume":"38","author":"Shoenfeld","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib25","doi-asserted-by":"crossref","first-page":"J254","DOI":"10.1016\/j.jaut.2011.12.001","article-title":"Sex differences and genomics in autoimmune diseases","volume":"38","author":"Amur","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib26","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.4049\/jimmunol.1301092","article-title":"Antimitochondrial antibody recognition and structural integrity of the inner lipoyl domain of the E2 subunit of pyruvate dehydrogenase complex","volume":"191","author":"Wang","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2012.12.007","article-title":"Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA","volume":"41","author":"Leung","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaut.2013.02.002","article-title":"Epigenetic dysregulation in salivary glands from patients with primary Sjogren's syndrome may be ascribed to infiltrating B cells","volume":"41","author":"Thabet","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaut.2013.01.005","article-title":"Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus","volume":"41","author":"Zhang","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","article-title":"Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases","volume":"33","author":"Cooper","year":"2009","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","article-title":"Autoimmune hepatitis: a comprehensive review","volume":"41","author":"Liberal","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2013.05.003","article-title":"Rethinking mechanisms of autoimmune pathogenesis","volume":"45","author":"Pillai","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaut.2012.06.002","article-title":"Genetic variations in interleukin-12 related genes in immune-mediated diseases","volume":"39","author":"van Wanrooij","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jaut.2012.05.001","article-title":"Criteria for environmentally associated autoimmune diseases","volume":"39","author":"Miller","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib35","article-title":"Introducing polyautoimmunity: secondary autoimmune diseases no longer exist","volume":"2012","author":"Rojas-Villarraga","year":"2012","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.jaut.2014.05.001_bib36","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.humimm.2013.06.020","article-title":"Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis","volume":"74","author":"Klein","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1741-7015-11-73","article-title":"How do autoimmune diseases cluster in families? A systematic review and meta-analysis","volume":"11","author":"Cardenas-Roldan","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1375\/twin.14.2.129","article-title":"Utilizing twins concordance rates to infer the predisposition to myasthenia gravis","volume":"14","author":"Ramanujam","year":"2011","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/j.jaut.2014.05.001_bib39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","article-title":"Genetic basis of myasthenia gravis \u2013 a comprehensive review","volume":"52","author":"Avidan","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaut.2013.04.004","article-title":"The Idd13 congenic interval defines the number of merocytic dendritic cells, a novel trait associated with autoimmune diabetes susceptibility","volume":"43","author":"Pelletier","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaut.2013.04.003","article-title":"Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients","volume":"43","author":"Coit","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2012.12.006","article-title":"Overexpression of X-linked genes in T cells from women with lupus","volume":"41","author":"Hewagama","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaut.2013.01.008","article-title":"Genetic susceptibility to SLE: recent progress from GWAS","volume":"41","author":"Cui","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.01.010","article-title":"The critical importance of epigenetics in autoimmunity","volume":"41","author":"Lu","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2012.01.008","article-title":"Genetics of Sjogren's syndrome in the genome-wide association era","volume":"39","author":"Ice","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib46","first-page":"307","article-title":"Autoimmune diseases and HLA","volume":"10","author":"Nelson","year":"1990","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib47","doi-asserted-by":"crossref","first-page":"18680","DOI":"10.1073\/pnas.0909307106","article-title":"Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases","volume":"106","author":"International MHC","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/01.wnl.0000339103.08830.86","article-title":"HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5","volume":"72","author":"Bartoccioni","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.001_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaut.2013.12.007","article-title":"T\u00a0cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients","volume":"52","author":"Marino","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib50","doi-asserted-by":"crossref","first-page":"e36603","DOI":"10.1371\/journal.pone.0036603","article-title":"Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population","volume":"7","author":"Maniaol","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2014.05.001_bib51","unstructured":"Chuang W-y, Str\u00f6bel P, Nix W, Schalke B, Gold R, Inoue M, et\u00a0al. Update on late-onset myasthenia gravis: a CTLA4 low genotype association and low-for-age thymic output of na\u00efve T-Cells."},{"key":"10.1016\/j.jaut.2014.05.001_bib52","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1399-0039.1992.tb02104.x","article-title":"Distribution of HLA class II alleles among Scandinavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non[DRB1*03,DQA1*0501,DQB1*0201] class II homozygotes?","volume":"40","author":"Skarsvag","year":"1992","journal-title":"Tissue antigens"},{"key":"10.1016\/j.jaut.2014.05.001_bib53","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diabetes.54.6.1879","article-title":"\u201cExtended\u201d A1, B8, DR3 haplotype shows remarkable linkage disequilibrium but is similar to nonextended haplotypes in terms of diabetes risk","volume":"54","author":"Ide","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2014.05.001_bib54","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2265.1980.tb03421.x","article-title":"Graves' disease and HLA: clinical and epidemiologic associations","volume":"13","author":"Farid","year":"1980","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jaut.2014.05.001_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0198-8859(97)00024-4","article-title":"Invited anniversary review: HLA associated diseases","volume":"53","author":"Thorsby","year":"1997","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jneuroim.2011.05.008","article-title":"Concomitant autoimmunity in myasthenia gravis\u2013lack of association with IgA deficiency","volume":"236","author":"Ramanujam","year":"2011","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.51","article-title":"VAV1 and BAFF, via NFkB pathway, are genetic risk factors for Myasthenia Gravis","author":"Avidan","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib58","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1210\/jc.2004-2236","article-title":"Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes","volume":"90","author":"Golden","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jaut.2014.05.001_bib59","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/leu.2010.17","article-title":"Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma","volume":"24","author":"Abdou","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.jaut.2014.05.001_bib60","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1073\/pnas.94.7.3195","article-title":"Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation","volume":"94","author":"Wilson","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib61","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0198-8859(96)00064-X","article-title":"Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion","volume":"50","author":"Garcia-Merino","year":"1996","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib62","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0198-8859(01)00264-6","article-title":"A\u00a0genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity","volume":"62","author":"Lio","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib63","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0753-3322(03)00079-9","article-title":"Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype","volume":"57","author":"Candore","year":"2003","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jaut.2014.05.001_bib64","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1196\/annals.1423.017","article-title":"Genetic control of immune response in carriers of the 8.1 ancestral haplotype: correlation with levels of IgG subclasses: its relevance in the pathogenesis of autoimmune diseases","volume":"1110","author":"Candore","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2014.05.001_bib65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/08820139709022690","article-title":"HLA-B8,DR3 haplotype affects lymphocyte blood levels","volume":"26","author":"Caruso","year":"1997","journal-title":"Immunol Invest"},{"key":"10.1016\/j.jaut.2014.05.001_bib66","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/ard.2007.075044","article-title":"Epistasis between the MHC and the RCA alpha block in primary Sjogren syndrome","volume":"67","author":"Lester","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2014.05.001_bib67","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejim.2010.05.010","article-title":"A\u00a03-factor epistatic model predicts digital ulcers in Italian scleroderma patients","volume":"21","author":"Beretta","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-5728(98)00253-7","article-title":"Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis","volume":"94","author":"Huang","year":"1999","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib69","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0198-8859(99)00062-2","article-title":"A\u00a0susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C","volume":"60","author":"Janer","year":"1999","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib70","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.coi.2012.09.003","article-title":"GWAS implicates a role for quantitative immune traits and threshold effects in risk for human autoimmune disorders","volume":"24","author":"Gregersen","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib71","doi-asserted-by":"crossref","first-page":"A479","DOI":"10.1016\/j.autrev.2011.11.022","article-title":"The influence of sex and gender on the immune response","volume":"11","author":"Oertelt-Prigione","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2796.2007.01879.x","article-title":"Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis","volume":"263","author":"Wang","year":"2008","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib73","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ana.20751","article-title":"Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravis","volume":"59","author":"Vandiedonck","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib74","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.humimm.2007.02.003","article-title":"Polymorphisms of interferon-gamma, interleukin-10, and interleukin-12 genes in myasthenia gravis","volume":"68","author":"Yilmaz","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib75","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1405.027","article-title":"Genetic factors in autoimmune myasthenia gravis","volume":"1132","author":"Giraud","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2014.05.001_bib76","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12016-012-8324-0","article-title":"The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis","volume":"43","author":"Kawata","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib77","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.it.2013.01.004","article-title":"Regulation of nuclear factor-kappaB in autoimmunity","volume":"34","author":"Sun","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib78","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1016\/j.febslet.2011.04.032","article-title":"Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?","volume":"585","author":"Burn","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaut.2014.05.001_bib79","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/gene.2012.46","article-title":"Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue","volume":"13","author":"Zheng","year":"2012","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaut.2014.05.001_bib80","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1084\/jem.189.1.111","article-title":"Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase","volume":"189","author":"Cloutier","year":"1999","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib81","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jneuroim.2008.04.004","article-title":"PTPN22 R620W promotes production of anti-AChR autoantibodies and IL-2 in myasthenia gravis","volume":"197","author":"Lefvert","year":"2008","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib82","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nmd.2011.09.003","article-title":"PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data","volume":"22","author":"Provenzano","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jaut.2014.05.001_bib83","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U","article-title":"Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP","volume":"29","author":"Gjorloff-Wingren","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib84","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/ng1673","article-title":"Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant","volume":"37","author":"Vang","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaut.2014.05.001_bib85","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.4049\/jimmunol.179.7.4704","article-title":"Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes","volume":"179","author":"Rieck","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib86","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.4049\/jimmunol.0713370","article-title":"Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling","volume":"182","author":"Arechiga","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib87","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.autrev.2013.10.011","article-title":"The role of PTPN22 in autoimmunity: learning from mice","volume":"13","author":"Zheng","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib88","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4049\/jimmunol.1302418","article-title":"PTPN22 controls the germinal center by influencing the numbers and activity of T follicular helper cells","volume":"192","author":"Maine","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib89","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2012.12.001","article-title":"Expansion of circulating counterparts of follicular helper T cells in patients with myasthenia gravis","volume":"256","author":"Luo","year":"2013","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib90","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","article-title":"Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-alpha","volume":"52","author":"Gradolatto","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib91","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1073\/pnas.91.11.4668","article-title":"Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis","volume":"91","author":"Garchon","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib92","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.gene.6364041","article-title":"Association of the gene encoding the delta-subunit of the muscle acetylcholine receptor (CHRND) with acquired autoimmune myasthenia gravis","volume":"5","author":"Giraud","year":"2004","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaut.2014.05.001_bib93","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0165-5728(97)00085-4","article-title":"No evidence for an association of AChR beta-subunit gene (CHRNB1) with myasthenia gravis","volume":"78","author":"Djabiri","year":"1997","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib94","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mus.10548","article-title":"Lack of association between acetylcholine receptor epsilon polymorphisms and early-onset myasthenia gravis","volume":"29","author":"Bonifati","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2014.05.001_bib95","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2174\/138920211798120763","article-title":"Hashimoto's thyroiditis: from genes to the disease","volume":"12","author":"Zaletel","year":"2011","journal-title":"Curr Genomics"},{"key":"10.1016\/j.jaut.2014.05.001_bib96","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/er.2008-0015","article-title":"Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms","volume":"29","author":"Huber","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib97","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1212\/01.WNL.0000079372.54703.A8","article-title":"Myelin basic protein gene is associated with MS in DR4- and DR5-positive Italians and Russians","volume":"61","author":"Guerini","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.001_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8529(03)00082-3","article-title":"Genetics of type 1 diabetes","volume":"33","author":"Pugliese","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jaut.2014.05.001_bib99","doi-asserted-by":"crossref","first-page":"J207","DOI":"10.1016\/j.jaut.2009.12.006","article-title":"Epigenetics and autoimmunity","volume":"34","author":"Brooks","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib100","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.semarthrit.2013.10.003","article-title":"Epigenetics and methylation in the rheumatic diseases","volume":"43","author":"Zufferey","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.05.001_bib101","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2302\/kjm.60.10","article-title":"Epigenetics and autoimmunity, with special emphasis on methylation","volume":"60","author":"Renaudineau","year":"2011","journal-title":"Keio J Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib102","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clim.2012.07.006","article-title":"CD40L demethylation in CD4(+) T cells from women with rheumatoid arthritis","volume":"145","author":"Liao","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib103","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.4049\/jimmunol.179.9.6352","article-title":"Demethylation of CD40LG on the inactive X in T cells from women with lupus","volume":"179","author":"Lu","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib104","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.34376","article-title":"DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility","volume":"64","author":"Lian","year":"2012","journal-title":"Arthritis rheumatism"},{"key":"10.1016\/j.jaut.2014.05.001_bib105","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ni.f.209","article-title":"MicroRNAs: new regulators of immune cell development and function","volume":"9","author":"Baltimore","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib106","first-page":"163","article-title":"MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases","volume":"157","author":"Dai","year":"2011","journal-title":"Transl Res J Lab Clin Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib107","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jim.2013.10.001","article-title":"High degree of correlation between whole blood and PBMC expression levels of miR-155 and miR-146a in healthy controls and rheumatoid arthritis patients","volume":"400\u2013-401","author":"Mookherjee","year":"2013","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jaut.2014.05.001_bib108","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","article-title":"Requirement of bic\/microRNA-155 for normal immune function","volume":"316","author":"Rodriguez","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jaut.2014.05.001_bib109","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.immuni.2008.11.010","article-title":"Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein","volume":"30","author":"Lu","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2014.05.001_bib110","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.4049\/jimmunol.0803162","article-title":"Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells","volume":"182","author":"Kohlhaas","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib111","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2010.09.009","article-title":"MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development","volume":"33","author":"O'Connell","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2014.05.001_bib112","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cytogfr.2011.05.002","article-title":"Role of microRNA-155 in autoimmunity","volume":"22","author":"Leng","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib113","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cei.12265","article-title":"Delivery of an miR155 inhibitor by anti-CD20 single chain antibody into B cells reduces the AChR-specific auto-antibodies and ameliorates experimental autoimmune myasthenia gravis","volume":"176","author":"Wang","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib114","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.0610731104","article-title":"MicroRNA-155 is induced during the macrophage inflammatory response","volume":"104","author":"O'Connell","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib115","first-page":"777","article-title":"Role of miR-155 in myasthenia gravis and effect of dexamethasone on miR-155","volume":"37","author":"Chen","year":"2012","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.jaut.2014.05.001_bib116","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2007.10.009","article-title":"microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells","volume":"27","author":"Vigorito","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2014.05.001_bib117","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/08830180903208303","article-title":"microRNAs in inflammation","volume":"28","author":"Sonkoly","year":"2009","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib118","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neulet.2013.09.014","article-title":"Altered expression of miR-146a in myasthenia gravis","volume":"555","author":"Lu","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jaut.2014.05.001_bib119","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1182\/blood-2012-08-452425","article-title":"Forced miR-146a expression causes autoimmune lymphoproliferative syndrome in mice via downregulation of Fas in germinal center B cells","volume":"121","author":"Guo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2014.05.001_bib120","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1084\/jem.20112218","article-title":"miR-146a controls the resolution of T cell responses in mice","volume":"209","author":"Yang","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib121","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib122","article-title":"Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker","author":"Punga","year":"2013","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib123","doi-asserted-by":"crossref","first-page":"e91927","DOI":"10.1371\/journal.pone.0091927","article-title":"Analysis of serum miRNA profiles of myasthenia gravis patients","volume":"9","author":"Nogales-Gadea","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2014.05.001_bib124","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.23880","article-title":"Circulating microRNAs as biomarkers for disease staging in multiple sclerosis","volume":"73","author":"Gandhi","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib125","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.37890","article-title":"Circulating microRNA expression profiles associated with systemic lupus erythematosus","volume":"65","author":"Carlsen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.05.001_bib126","doi-asserted-by":"crossref","DOI":"10.1111\/cen.12432","article-title":"Circulating microRNAs in autoimmune thyroid diseases","author":"Yamada","year":"2014","journal-title":"Clin Endocrinol (Oxford)"},{"key":"10.1016\/j.jaut.2014.05.001_bib127","doi-asserted-by":"crossref","first-page":"J109","DOI":"10.1016\/j.jaut.2011.10.003","article-title":"Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity","volume":"38","author":"Quintero","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib128","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm1295-1279","article-title":"Genetic control of the CD4\/CD8 T-cell ratio in humans","volume":"1","author":"Amadori","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0928-8244(03)00202-5","article-title":"Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone","volume":"38","author":"Beagley","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.jaut.2014.05.001_bib130","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.molimm.2004.05.014","article-title":"Hormonal modulation of B cell development and repertoire selection","volume":"42","author":"Grimaldi","year":"2005","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib131","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000331437","article-title":"Estrogen stimulates Th2 cytokine production and regulates the compartmentalisation of eosinophils during allergen challenge in a mouse model of asthma","volume":"158","author":"Cai","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib132","doi-asserted-by":"crossref","first-page":"J282","DOI":"10.1016\/j.jaut.2011.11.013","article-title":"Sex affects immunity","volume":"38","author":"Pennell","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib133","doi-asserted-by":"crossref","first-page":"A377","DOI":"10.1016\/j.autrev.2011.11.001","article-title":"The role of gender and organ specific autoimmunity","volume":"11","author":"Nussinovitch","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib134","doi-asserted-by":"crossref","first-page":"e19658","DOI":"10.1371\/journal.pone.0019658","article-title":"Pregnancy and the risk of autoimmune disease","volume":"6","author":"Khashan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2014.05.001_bib135","doi-asserted-by":"crossref","first-page":"A422","DOI":"10.1016\/j.autrev.2011.11.020","article-title":"Sex differences in spontaneous versus induced animal models of autoimmunity","volume":"11","author":"Lee","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib136","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1084\/jem.147.6.1568","article-title":"Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB\/NZW F1 mice","volume":"147","author":"Roubinian","year":"1978","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib137","first-page":"137","article-title":"Effect of castration on the appearance of diabetes in NOD mouse","volume":"30","author":"Makino","year":"1981","journal-title":"Jikken Dobutsu"},{"key":"10.1016\/j.jaut.2014.05.001_bib138","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1196\/annals.1405.019","article-title":"Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis","volume":"1132","author":"Le Panse","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2014.05.001_bib139","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/jnnp.2006.102517","article-title":"Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands","volume":"78","author":"Niks","year":"2007","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jaut.2014.05.001_bib141","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib142","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1073\/pnas.0307915100","article-title":"Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene","volume":"101","author":"Shim","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib143","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.38048","article-title":"Gr-1(high) CD11b+ cells suppress B cell differentiation and lupus-like disease in lupus-prone male mice","volume":"65","author":"Trigunaite","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.05.001_bib144","first-page":"115","article-title":"Localization of estrogen receptors and estrogen receptor-mRNA in female mouse thymus","volume":"20","author":"Kawashima","year":"1992","journal-title":"Thymus"},{"key":"10.1016\/j.jaut.2014.05.001_bib145","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1210\/en.2004-1003","article-title":"Differential estrogen receptor expression in autoimmune myasthenia gravis","volume":"146","author":"Nancy","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2014.05.001_bib146","first-page":"2167","article-title":"Characteristics of late-onset myasthenia gravis","volume":"259","author":"Zivkovic","year":"2012","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib147","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/ard.2007.069831","article-title":"Vitamin D and autoimmunity: new aetiological and therapeutic considerations","volume":"66","author":"Arnson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2014.05.001_bib148","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-3083.2008.02127.x","article-title":"The complex role of vitamin D in autoimmune diseases","volume":"68","author":"Szodoray","year":"2008","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib149","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10067-012-2159-1","article-title":"What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidence","volume":"32","author":"Nisar","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaut.2014.05.001_bib150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2005.05.009","article-title":"Vitamin D deficiency in systemic lupus erythematosus","volume":"5","author":"Kamen","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib151","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/j.1468-1331.2012.03773.x","article-title":"Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study","volume":"19","author":"Askmark","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib152","doi-asserted-by":"crossref","first-page":"876319","DOI":"10.1155\/2013\/876319","article-title":"Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation","volume":"2013","author":"Scolletta","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaut.2014.05.001_bib153","first-page":"881","article-title":"Vitamin D and the immune system","volume":"59","author":"Aranow","year":"2011","journal-title":"J\u00a0Investig Med Off Publ Am Fed Clin Res"},{"key":"10.1016\/j.jaut.2014.05.001_bib154","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1074\/jbc.C109.071225","article-title":"Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2\/CARD15-defensin beta2 innate immune pathway defective in Crohn disease","volume":"285","author":"Wang","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaut.2014.05.001_bib155","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.4049\/jimmunol.174.9.5324","article-title":"Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis","volume":"174","author":"Feferman","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib156","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2009.01.021","article-title":"Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3","volume":"209","author":"Feferman","year":"2009","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib157","doi-asserted-by":"crossref","first-page":"15449","DOI":"10.1073\/pnas.1200072109","article-title":"Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment","volume":"109","author":"Coussens","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib158","doi-asserted-by":"crossref","first-page":"e66019","DOI":"10.1371\/journal.pone.0066019","article-title":"Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents","volume":"8","author":"Hoffmann","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2014.05.001_bib159","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.phrs.2012.10.020","article-title":"The influence of diet on the gut microbiota","volume":"69","author":"Scott","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jaut.2014.05.001_bib160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2014.05.001_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04139.x","article-title":"The \u2018hygiene hypothesis\u2019 for autoimmune and allergic diseases: an update","volume":"160","author":"Okada","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib162","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/gmic.19320","article-title":"The role of gut microbiota in immune homeostasis and autoimmunity","volume":"3","author":"Wu","year":"2012","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jaut.2014.05.001_bib163","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.chom.2012.09.009","article-title":"Intestinal commensal microbes as immune modulators","volume":"12","author":"Ivanov","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jaut.2014.05.001_bib164","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.immuni.2013.08.013","article-title":"Gender bias in autoimmunity is influenced by microbiota","volume":"39","author":"Yurkovetskiy","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2014.05.001_bib165","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.001","article-title":"Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells","volume":"32","author":"Wu","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2014.05.001_bib166","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/ana.22344","article-title":"Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease","volume":"69","author":"Ochoa-Reparaz","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib167","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature10554","article-title":"Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination","volume":"479","author":"Berer","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2014.05.001_bib168","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1756283X12459294","article-title":"Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation","volume":"6","author":"Hemarajata","year":"2013","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.jaut.2014.05.001_bib169","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.molimm.2007.12.010","article-title":"Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions","volume":"45","author":"So","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2006.11.005","article-title":"Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation","volume":"123","author":"Kim","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib171","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaci.2005.03.036","article-title":"Selective probiotic bacteria induce IL-10-producing regulatory T cells in\u00a0vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin","volume":"115","author":"Smits","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052119","article-title":"Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis","volume":"7","author":"Chae","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2014.05.001_bib173","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1073\/pnas.0904055107","article-title":"Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders","volume":"107","author":"Kwon","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib174","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/ped.12243","article-title":"Differences in the gut microbiota of healthy children and those with type 1 diabetes","volume":"56","author":"Soyucen","year":"2014","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jaut.2014.05.001_bib175","doi-asserted-by":"crossref","first-page":"e01202","DOI":"10.7554\/eLife.01202","article-title":"Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis","volume":"2","author":"Scher","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.jaut.2014.05.001_bib176","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.nut.2013.09.007","article-title":"Probiotic supplementation improves inflammatory\u00a0status in patients with rheumatoid arthritis","volume":"30","author":"Vaghef-Mehrabany","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.jaut.2014.05.001_bib177","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.cgh.2009.07.016","article-title":"The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis","volume":"7","author":"Sood","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2014.05.001_bib178","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bpg.2013.03.003","article-title":"Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease?","volume":"27","author":"Vrieze","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jaut.2014.05.001_bib179","series-title":"Autoimmune disease: mechanisms","first-page":"1","author":"Fairweather","year":"2007"},{"key":"10.1016\/j.jaut.2014.05.001_bib180","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/978-0-387-46401-5_19","article-title":"Curcumin and autoimmune disease","volume":"595","author":"Bright","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaut.2014.05.001_bib181","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2119\/molmed.2011.00311","article-title":"Influence of dietary components on regulatory T cells","volume":"18","author":"Issazadeh-Navikas","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib182","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature11868","article-title":"Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells","volume":"496","author":"Kleinewietfeld","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2014.05.001_bib183","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature11984","article-title":"Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1","volume":"496","author":"Wu","year":"2013","journal-title":"Nature"},{"issue":"Suppl.","key":"10.1016\/j.jaut.2014.05.001_bib184","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2005.09.024","article-title":"Infections and autoimmune diseases","volume":"25","author":"Bach","year":"2005","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib185","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.it.2009.05.005","article-title":"Infections and autoimmunity\u2013friends or foes?","volume":"30","author":"Kivity","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib186","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1212\/WNL.0b013e3181d7d884","article-title":"Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis","volume":"74","author":"Cavalcante","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.001_bib187","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.4049\/jimmunol.181.6.4019","article-title":"Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation","volume":"181","author":"Deng","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib188","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1128\/JVI.00597-08","article-title":"Rotavirus infection accelerates type 1 diabetes in mice with established insulitis","volume":"82","author":"Graham","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.05.001_bib189","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.23791","article-title":"Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis","volume":"73","author":"Cufi","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib190","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/jvi.61.5.1416-1420.1987","article-title":"Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV\/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d","volume":"61","author":"Nemerow","year":"1987","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jaut.2014.05.001_bib191","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/intimm\/11.11.1841","article-title":"Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes","volume":"11","author":"Fischer","year":"1999","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib192","article-title":"CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis","volume":"2012","author":"Pender","year":"2012","journal-title":"Autoimmun Dis"},{"key":"10.1016\/j.jaut.2014.05.001_bib193","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(71)91937-4","article-title":"Raised antibody titres to E.B. virus in systemic lupus erythematosus","volume":"1","author":"Evans","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2014.05.001_bib194","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","article-title":"Environmental risk factors for multiple sclerosis. Part I: the role of infection","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib195","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.410170412","article-title":"Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis","volume":"17","author":"Sumaya","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib196","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-0029-1211428","article-title":"Epstein-Barr virus serology in patients with autoimmune thyroiditis","volume":"104","author":"Vrbikova","year":"1996","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jaut.2014.05.001_bib197","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1468-1331.2011.03636.x","article-title":"High anti-EBNA-1 IgG levels are associated with early-onset myasthenia gravis","volume":"19","author":"Csuka","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib198","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1365-2249.1998.00675.x","article-title":"Abnormal T cell receptor V gene usage in myasthenia gravis: prevalence and characterization of expanded T cell populations","volume":"113","author":"Xu","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib199","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ana.410410609","article-title":"Altered intrathymic T-cell repertoire in human myasthenia gravis","volume":"41","author":"Truffault","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1084\/jem.184.2.349","article-title":"Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis","volume":"184","author":"Zhang","year":"1996","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib201","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2013.12.005","article-title":"Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis","volume":"52","author":"Yi","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib202","doi-asserted-by":"crossref","first-page":"J266","DOI":"10.1016\/j.jaut.2009.11.012","article-title":"Drugs and autoimmunity\u2013a contemporary review and mechanistic approach","volume":"34","author":"Chang","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib203","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1749-6632.1998.tb10961.x","article-title":"Drug-induced autoimmune myasthenia Gravisa","volume":"841","author":"Penn","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2014.05.001_bib204","first-page":"387","article-title":"D-penicillamine induced myasthenia gravis: clinical, serological and genetic findings","volume":"11","author":"Drosos","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaut.2014.05.001_bib205","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2012.05.011","article-title":"Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine","volume":"250","author":"Poulas","year":"2012","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib206","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1021\/tx900128p","article-title":"D-penicillamine-induced autoimmunity: relationship to macrophage activation","volume":"22","author":"Li","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jaut.2014.05.001_bib207","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/toxsci\/kfq392","article-title":"Involvement of T helper 17 cells in D-penicillamine-induced autoimmune disease in Brown Norway rats","volume":"120","author":"Zhu","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jaut.2014.05.001_bib208","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0079-6603(08)60026-4","article-title":"The interferon genes","volume":"33","author":"Weissmann","year":"1986","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"10.1016\/j.jaut.2014.05.001_bib209","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/294768a0","article-title":"Evidence that types I and II interferons have different receptors","volume":"294","author":"Branca","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2014.05.001_bib210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2008.12.008","article-title":"Interferon alpha and neuromuscular disorders","volume":"207","author":"St\u00fcbgen","year":"2009","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib211","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/14737175.7.3.227","article-title":"Interferon-beta1b in multiple sclerosis","volume":"7","author":"Buttmann","year":"2007","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jaut.2014.05.001_bib212","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","article-title":"A\u00a0survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon","volume":"24","author":"Fattovich","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2014.05.001_bib213","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-8278(96)80113-9","article-title":"Side effects of high-dose interferon therapy for chronic hepatitis C","volume":"25","author":"Okanoue","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2014.05.001_bib214","first-page":"104","article-title":"A\u00a0meta-analysis of patients with chronic hepatitis C treated with interferon-alpha to determine the risk of autoimmune thyroiditis","volume":"41","author":"Andrade","year":"2011","journal-title":"Acta Gastroenterol Latinoam"},{"key":"10.1016\/j.jaut.2014.05.001_bib215","doi-asserted-by":"crossref","first-page":"J322","DOI":"10.1016\/j.jaut.2009.11.008","article-title":"Hepatitis C and interferon induced thyroiditis","volume":"34","author":"Tomer","year":"2010","journal-title":"J\u00a0Autoimmun"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.jaut.2014.05.001_bib216","first-page":"S57","article-title":"Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b","volume":"6","author":"Speciale","year":"2000","journal-title":"J\u00a0Neurovirol"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jaut.2014.05.001_bib217","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/ar2886","article-title":"Type I interferon in organ-targeted autoimmune and inflammatory diseases","volume":"12","author":"Crow","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaut.2014.05.001_bib218","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.45.2.382","article-title":"Myasthenia gravis during interferon alfa therapy","volume":"45","author":"Batocchi","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.001_bib219","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib220","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.4049\/jimmunol.1002631","article-title":"IFN-alpha mediates the development of autoimmunity both by direct tissue toxicity and through immune cell recruitment mechanisms","volume":"186","author":"Akeno","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib221","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/BOR.0b013e328010c547","article-title":"Syndromes and complications of interferon therapy","volume":"19","author":"Borg","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaut.2014.05.001_bib222","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3899\/jrheum.100809","article-title":"Development of inflammatory bowel disease in patients with juvenile idiopathic arthritis treated with etanercept","volume":"38","author":"van Dijken","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2014.05.001_bib223","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0165-5728(01)00473-8","article-title":"Treatment of experimental autoimmune myasthenia gravis with recombinant human tumor necrosis factor receptor Fc protein","volume":"122","author":"Christadoss","year":"2002","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib224","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1212\/01.WNL.0000147242.92691.71","article-title":"Etanercept treatment in corticosteroid-dependent myasthenia gravis","volume":"63","author":"Rowin","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.001_bib225","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/mus.21280","article-title":"Myasthenia gravis associated with etanercept therapy","volume":"39","author":"Fee","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2014.05.001_bib226","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1002\/eji.1830270822","article-title":"Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system","volume":"27","author":"Korner","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib227","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.autrev.2013.09.002","article-title":"Demyelination and other neurological adverse events after anti-TNF therapy","volume":"13","author":"Kaltsonoudis","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib228","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature11307","article-title":"TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis","volume":"488","author":"Gregory","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2014.05.001_bib229","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.autrev.2012.10.021","article-title":"Immunogenicity and autoimmunity during anti-TNF therapy","volume":"12","author":"Atzeni","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.autrev.2007.03.003","article-title":"Biological and clinical effects of anti-TNFalpha treatment","volume":"7","author":"Valesini","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib231","first-page":"153","article-title":"Thyroid antibodies in thyroid diseases","author":"Bottazzo","year":"1982","journal-title":"Ciba Found Symp"},{"key":"10.1016\/j.jaut.2014.05.001_bib232","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2265.1987.tb01168.x","article-title":"Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis","volume":"27","author":"Kraiem","year":"1987","journal-title":"Clin Endocrinol (Oxford)"},{"key":"10.1016\/j.jaut.2014.05.001_bib233","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.autrev.2011.10.021","article-title":"Autoantibodies in lupus: culprits or passive bystanders?","volume":"11","author":"Rekvig","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib234","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/1744666X.4.1.43","article-title":"Effect of complement and its regulation on myasthenia gravis pathogenesis","volume":"4","author":"Kusner","year":"2008","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib235","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/WCO.0b013e328364d6cd","article-title":"Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation","volume":"26","author":"Le Panse","year":"2013","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib236","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"Tuzun","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib237","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.4049\/jimmunol.151.11.6442","article-title":"Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis","volume":"151","author":"Asher","year":"1993","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib238","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1172\/JCI117302","article-title":"Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction","volume":"94","author":"Guyon","year":"1994","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2014.05.001_bib239","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1172\/JCI1248","article-title":"Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss","volume":"102","author":"Guyon","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2014.05.001_bib240","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase","volume":"116","author":"Shigemoto","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2014.05.001_bib241","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.autrev.2013.03.005","article-title":"Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis","volume":"12","author":"Mori","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib242","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib243","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2014.05.001_bib244","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/asheducation-2007.1.210","article-title":"The biology of the germinal center","author":"Natkunam","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jaut.2014.05.001_bib245","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri1786","article-title":"Lymphoid neogenesis in chronic inflammatory diseases","volume":"6","author":"Aloisi","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib246","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2249.1990.tb05174.x","article-title":"Hashimoto's thyroiditis manifesting monoclonal lymphocytic infiltration","volume":"79","author":"Matsubayashi","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib247","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0002-9440(10)61762-2","article-title":"Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers","volume":"159","author":"Armengol","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2014.05.001_bib248","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1172\/JCI3234","article-title":"Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren's syndrome","volume":"102","author":"Stott","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2014.05.001_bib249","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.11311","article-title":"Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome","volume":"48","author":"Salomonsson","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.05.001_bib250","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-3083.1995.tb03596.x","article-title":"The identification of germinal centres and follicular dendritic cell networks in rheumatoid synovial tissue","volume":"41","author":"Randen","year":"1995","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib251","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1073\/pnas.93.1.221","article-title":"Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis","volume":"93","author":"Schroder","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib252","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI3568","article-title":"Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis","volume":"102","author":"Qin","year":"1998","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2014.05.001_bib253","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jaut.2014.05.001_bib254","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/jcp.23.2.95","article-title":"Immunological and histological studies in primary biliary cirrhosis","volume":"23","author":"Hadziyannis","year":"1970","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jaut.2014.05.001_bib255","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1034\/j.1478-3231.2003.00866.x","article-title":"Local antigen-driven oligoclonal expansion of B cells in the liver portal areas of patients with primary biliary cirrhosis","volume":"23","author":"Sugimura","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.jaut.2014.05.001_bib256","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.178.1.547","article-title":"A\u00a0local antigen-driven humoral response is present in the inflammatory myopathies","volume":"178","author":"Bradshaw","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib257","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clim.2009.02.010","article-title":"Clonal expansion of B-cells in human systemic lupus erythematosus: evidence from studies before and after therapeutic B-cell depletion","volume":"132","author":"Sfikakis","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib258","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2013.03.011","article-title":"Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis","volume":"12","author":"Berrih-Aknin","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib259","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.4049\/jimmunol.145.7.2115","article-title":"Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis","volume":"145","author":"Leprince","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib260","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/eji.200939914","article-title":"Ectopic GC in the thymus of myasthenia gravis patients show characteristics of normal GC","volume":"40","author":"Zuckerman","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib261","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1172\/JCI115843","article-title":"Transplantation of thymic autoimmune microenvironment to severe combined immunodeficiency mice. A new model of myasthenia gravis","volume":"90","author":"Schonbeck","year":"1992","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2014.05.001_bib262","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/1531-8249(199910)46:4<559::AID-ANA3>3.0.CO;2-S","article-title":"Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis","volume":"46","author":"Aissaoui","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib263","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2013.12.008","article-title":"Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor","volume":"52","author":"Vrolix","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib264","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jneuroim.2008.05.010","article-title":"Serum BAFF expression\u00a0in patients with myasthenia gravis","volume":"199","author":"Kim","year":"2008","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib265","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib266","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.coi.2010.09.010","article-title":"Targeting BAFF in autoimmunity","volume":"22","author":"Davidson","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib267","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08916930903563491","article-title":"Thymic remodeling associated with hyperplasia in myasthenia gravis","volume":"43","author":"Le Panse","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2014.05.001_bib268","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.neurol.2013.02.005","article-title":"The thymus in autoimmune Myasthenia Gravis: paradigm for a tertiary lymphoid organ","volume":"169","author":"Weiss","year":"2013","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jaut.2014.05.001_bib269","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/art.21062","article-title":"Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome","volume":"52","author":"Barone","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.05.001_bib270","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1210\/jcem-68-4-744","article-title":"High endothelial venules present in lymphoid cell accumulations in thyroids affected by autoimmune disease: a study in men and BB rats of functional activity and development","volume":"68","author":"Kabel","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jaut.2014.05.001_bib271","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.imbio.2012.05.006","article-title":"SDF-1\/CXCL12 recruits B cells and antigen-presenting cells to the thymus of autoimmune myasthenia gravis patients","volume":"218","author":"Weiss","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaut.2014.05.001_bib272","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.imlet.2012.04.013","article-title":"Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases","volume":"145","author":"Corsiero","year":"2012","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaut.2014.05.001_bib273","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2012.12.003","article-title":"T-regs in autoimmune hepatitis-systemic lupus erythematosus\/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile","volume":"41","author":"Longhi","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib274","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2013.06.006","article-title":"Treg and CTLA-4: two intertwining pathways to immune tolerance","volume":"45","author":"Walker","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib275","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib276","doi-asserted-by":"crossref","first-page":"986789","DOI":"10.1155\/2013\/986789","article-title":"Th17 cells in immunity and autoimmunity","volume":"2013","author":"Bedoya","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib277","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib278","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2249.2006.03271.x","article-title":"Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients","volume":"147","author":"Feger","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib279","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/03009740701482800","article-title":"Accumulation of FoxP3-expressing CD4+CD25+ T cells with distinct chemokine receptors in synovial fluid of patients with active rheumatoid arthritis","volume":"36","author":"Jiao","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaut.2014.05.001_bib280","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2014.05.001_bib281","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.autrev.2013.03.009","article-title":"Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model","volume":"12","author":"Gertel-Lapter","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib282","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1530\/EJE-11-0879","article-title":"Function of regulatory T-cells improved by dexamethasone in Graves' disease","volume":"166","author":"Hu","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jaut.2014.05.001_bib283","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1756-5391.2010.01083.x","article-title":"The effects of immunosuppressive drugs on CD4(+) CD25(+) regulatory T cells: a systematic review of clinical and basic research","volume":"3","author":"Zhang","year":"2010","journal-title":"J\u00a0Evid Based Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib284","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2010-12-328187","article-title":"Functional human regulatory T cells fail to control autoimmune inflammation due to PKB\/c-akt hyperactivation in effector cells","volume":"118","author":"Wehrens","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2014.05.001_bib285","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/ard.2005.049924","article-title":"Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids","volume":"65","author":"Suarez","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2014.05.001_bib286","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4049\/jimmunol.0802046","article-title":"Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients","volume":"183","author":"Luther","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jaut.2014.05.001_bib287","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1007\/s10875-010-9394-5","article-title":"Immunomodulation by intravenous immunoglobulin: role of regulatory T cells","volume":"30","author":"Maddur","year":"2010","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib288","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaut.2013.12.017","article-title":"Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: aggravation and therapeutic potential","volume":"52","author":"Gur-Wahnon","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib289","article-title":"Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis","author":"Thiruppathi","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib290","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2567.2009.03053.x","article-title":"Regulatory T cells overturned: the effectors fight back","volume":"126","author":"Walker","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2014.05.001_bib291","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20131556","article-title":"Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection","volume":"211","author":"Srivastava","year":"2014","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib292","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/art.22414","article-title":"Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis","volume":"56","author":"van Amelsfort","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.05.001_bib293","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/eji.201041004","article-title":"The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function","volume":"41","author":"Herrath","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib294","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nm.3085","article-title":"Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis","volume":"19","author":"Nie","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib295","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2014.05.001_bib296","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clim.2008.12.008","article-title":"IL-1beta and IL-2 convert human Treg into T(H)17 cells","volume":"131","author":"Deknuydt","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib297","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation","volume":"13","author":"Korn","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib298","first-page":"121","article-title":"Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia","volume":"4","author":"Cohen-Kaminsky","year":"1993","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jaut.2014.05.001_bib299","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-0-387-89520-8_3","article-title":"Targeting TNF for treatment of Cancer and autoimmunity","volume":"647","author":"Sethi","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaut.2014.05.001_bib300","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ccr.2004.09.003","article-title":"Nuclear factor-kappaB: the enemy within","volume":"6","author":"Aggarwal","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jaut.2014.05.001_bib301","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/jaut.2002.0618","article-title":"Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis","volume":"19","author":"Duan","year":"2002","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib302","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/intimm\/12.10.1381","article-title":"Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis","volume":"12","author":"Wang","year":"2000","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib303","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","article-title":"TNF downmodulates the function of human CD4+CD25hi T-regulatory cells","volume":"108","author":"Valencia","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2014.05.001_bib304","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0161-5890(97)00052-7","article-title":"The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription","volume":"34","author":"Kroeger","year":"1997","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib305","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbadis.2009.01.007","article-title":"Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease","volume":"1792","author":"Elahi","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaut.2014.05.001_bib306","doi-asserted-by":"crossref","first-page":"R264","DOI":"10.1186\/ar4110","article-title":"Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis","volume":"14","author":"Toonen","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaut.2014.05.001_bib307","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archneur.56.4.457","article-title":"TNFA and TNFB polymorphisms in myasthenia gravis","volume":"56","author":"Skeie","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib308","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2370.1998.00129.x","article-title":"Tumour necrosis factor beta gene polymorphisms in myasthenia gravis","volume":"25","author":"Zelano","year":"1998","journal-title":"Eur J Immunogenet"},{"key":"10.1016\/j.jaut.2014.05.001_bib309","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm0198-078","article-title":"TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination","volume":"4","author":"Liu","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib310","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fimmu.2013.00290","article-title":"Interferons in Sjogren's syndrome: genes, mechanisms, and effects","volume":"4","author":"Li","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib311","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/rheumatology\/kep345","article-title":"Type I interferons have no major influence on humoral autoimmunity in rheumatoid arthritis","volume":"49","author":"Cantaert","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2014.05.001_bib312","doi-asserted-by":"crossref","DOI":"10.2337\/db13-1777","article-title":"A\u00a0type I interferon transcriptional signature precedes autoimmunity in children genetically at-risk of type 1 diabetes","author":"Ferreira","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2014.05.001_bib313","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/ard.2004.033753","article-title":"Type I interferon correlates with serological and clinical manifestations of SLE","volume":"64","author":"Dall'era","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2014.05.001_bib314","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clim.2013.02.013","article-title":"Anti-interferon alpha treatment in SLE","volume":"148","author":"Kirou","year":"2013","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"10.1016\/j.jaut.2014.05.001_bib315","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/rheumatology\/38.4.362","article-title":"The effects of interferon beta treatment on arthritis","volume":"38","author":"Tak","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2014.05.001_bib316","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.4049\/jimmunol.174.10.5941","article-title":"Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis","volume":"174","author":"Poea-Guyon","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib317","doi-asserted-by":"crossref","first-page":"7868","DOI":"10.4049\/jimmunol.177.11.7868","article-title":"Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia","volume":"177","author":"Le Panse","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib318","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2249.2003.02113.x","article-title":"Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and\/or myasthenia gravis","volume":"132","author":"Meager","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib319","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome","volume":"103","author":"Gottenberg","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib320","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2567.2010.03280.x","article-title":"Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses","volume":"131","author":"Golding","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2014.05.001_bib321","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2013.12.016","article-title":"Central role of interferon-beta in thymic events leading to myasthenia gravis","volume":"52","author":"Cufi","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib322","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","article-title":"The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis","volume":"108","author":"Meraouna","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2014.05.001_bib323","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaut.2013.12.018","article-title":"Thymoma-associated myasthenia gravis: on the search for a pathogen signature","volume":"52","author":"Cufi","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib324","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2013.12.013","article-title":"Innate immunity in myasthenia gravis thymus: pathogenic effects of toll-like receptor 4 signaling on autoimmunity","volume":"52","author":"Cordiglieri","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib325","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/icb.2010.132","article-title":"The role of Aire in clonal selection","volume":"89","author":"Taniguchi","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaut.2014.05.001_bib326","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/11.4.397","article-title":"Aire deficient mice develop multiple features of APECED phenotype and show altered immune response","volume":"11","author":"Ramsey","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaut.2014.05.001_bib327","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/JTO.0b013e3181f1f63f","article-title":"The autoimmune regulator AIRE in thymoma biology","volume":"5","author":"Marx","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jaut.2014.05.001_bib328","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-3083.2008.02106.x","article-title":"Aire deficiency causes increased susceptibility to streptozotocin-induced murine type 1 diabetes","volume":"67","author":"Hassler","year":"2008","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib329","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1210\/en.2008-1690","article-title":"Studies in mice deficient for the autoimmune regulator (Aire) and transgenic for the thyrotropin receptor reveal a role for Aire in tolerance for thyroid autoantigens","volume":"150","author":"Misharin","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2014.05.001_bib330","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaut.2010.09.007","article-title":"The susceptibility of Aire(-\/-) mice to experimental myasthenia gravis involves alterations in regulatory T cells","volume":"36","author":"Aricha","year":"2011","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib331","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jneuroim.2013.06.001","article-title":"Age dependent course of EAE in Aire-\/- mice","volume":"262","author":"Aharoni","year":"2013","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib332","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4049\/jimmunol.174.4.1862","article-title":"Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice","volume":"174","author":"Kuroda","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib333","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1172\/JCI26971","article-title":"Alteration of intra-pancreatic target-organ specificity by abrogation of Aire in NOD mice","volume":"116","author":"Niki","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2014.05.001_bib334","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.imlet.2007.08.010","article-title":"Graft-versus-host-like disease complicating thymoma: lack of AIRE expression as a cause of non-hereditary autoimmunity?","volume":"114","author":"Offerhaus","year":"2007","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaut.2014.05.001_bib335","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/eji.200535240","article-title":"Increased antigen presenting cell-mediated T cell activation in mice and patients without the autoimmune regulator","volume":"36","author":"Ramsey","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib336","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.2012.06843.x","article-title":"Experimental myasthenia gravis in Aire-deficient mice: a link between Aire and regulatory T cells","volume":"1275","author":"Aricha","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaut.2014.05.001_bib337","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11010-010-0464-z","article-title":"Age-related deregulation of Aire and peripheral tissue antigen genes in the\u00a0thymic stroma of non-obese diabetic (NOD) mice is associated with autoimmune type 1 diabetes mellitus (DM-1)","volume":"342","author":"Fornari","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jaut.2014.05.001_bib338","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1084\/jem.20102327","article-title":"Aire-dependent production of XCL1 mediates medullary accumulation of thymic dendritic cells and contributes to regulatory T cell development","volume":"208","author":"Lei","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib339","doi-asserted-by":"crossref","first-page":"18466","DOI":"10.1073\/pnas.0808205105","article-title":"AIRE regulates T-cell-independent B-cell responses through BAFF","volume":"105","author":"Lindh","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib340","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","article-title":"Updated assessment of the prevalence, spectrum and case definition of autoimmune disease","volume":"11","author":"Hayter","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib341","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00695233","article-title":"Morphometric analysis of small intestinal mucosa. II. Determination of lamina propria volumes; plasma cell and neutrophil populations within control and coeliac disease mucosae","volume":"403","author":"Dhesi","year":"1984","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.jaut.2014.05.001_bib342","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/gut.17.10.770","article-title":"Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations","volume":"17","author":"Meuwissen","year":"1976","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2014.05.001_bib343","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ana.410240408","article-title":"Dual-label immunocytochemistry of the active multiple sclerosis lesion: major histocompatibility complex and activation antigens","volume":"24","author":"Hayashi","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib344","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1212\/WNL.43.6.1167","article-title":"Myasthenia gravis: quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients","volume":"43","author":"Nakano","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.001_bib345","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jclinpath-2013-201917","article-title":"Infiltration of inflammatory cells expressing mitochondrial proteins around bile ducts and in biliary epithelial layer may be involved in the pathogenesis in primary biliary cirrhosis","volume":"67","author":"Sasaki","year":"2014","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jaut.2014.05.001_bib346","first-page":"169","article-title":"Synovial tissues collected from rheumatoid patients undergoing total joint arthroplasty express markers for acute inflammation","volume":"34","author":"Tucci","year":"1997","journal-title":"Biomed Sci Instrum"},{"key":"10.1016\/j.jaut.2014.05.001_bib347","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/path.1533","article-title":"Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome","volume":"202","author":"Lavie","year":"2004","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jaut.2014.05.001_bib348","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000185110","article-title":"The relationship of infiltrating renal leucocytes to disease activity in lupus and cryoglobulinaemic glomerulonephritis","volume":"50","author":"Castiglione","year":"1988","journal-title":"Nephron"},{"key":"10.1016\/j.jaut.2014.05.001_bib349","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jcla.21674","article-title":"Distribution of lymphocyte subpopulations in thyroid glands of human autoimmune thyroid disease","volume":"28","author":"Zha","year":"2014","journal-title":"J\u00a0Clin Lab Anal"},{"key":"10.1016\/j.jaut.2014.05.001_bib350","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00125-013-3125-4","article-title":"Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes","volume":"57","author":"Jorns","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2014.05.001_bib351","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.autrev.2011.10.004","article-title":"Are autoimmune diseases predictable?","volume":"11","author":"Tobon","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib352","first-page":"185","article-title":"Is there a common genetic basis for autoimmune diseases?","volume":"13","author":"Anaya","year":"2006","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib353","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1056\/NEJMoa0807917","article-title":"Shared and distinct genetic variants in type 1 diabetes and celiac disease","volume":"359","author":"Smyth","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib354","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.autrev.2005.06.009","article-title":"Non-HLA associations with autoimmune diseases","volume":"5","author":"Serrano","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib355","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/anr.1780320410","article-title":"Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjogren's syndrome","volume":"32","author":"Arnett","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.05.001_bib356","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2007.11.010","article-title":"The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology","volume":"30","author":"Jacobson","year":"2008","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib357","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.arcmed.2014.03.002","article-title":"HLA-DR polymorphism and primary biliary cirrhosis: evidence from a meta-analysis","volume":"45","author":"Li","year":"2014","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jaut.2014.05.001_bib358","doi-asserted-by":"crossref","first-page":"e36140","DOI":"10.1371\/journal.pone.0036140","article-title":"Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1","volume":"7","author":"Matesanz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2014.05.001_bib359","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/gut.45.3.395","article-title":"HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis","volume":"45","author":"Stokkers","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2014.05.001_bib360","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/eji.201344270","article-title":"Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis","volume":"44","author":"Carbone","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib361","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.autrev.2014.02.002","article-title":"Genome-wide association studies in Sjogren's syndrome: what do the genes tell us about disease pathogenesis?","volume":"13","author":"Burbelo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib362","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12020-010-9317-5","article-title":"Analysis of thyroglobulin gene polymorphisms in patients with autoimmune thyroiditis","volume":"37","author":"Caputo","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.jaut.2014.05.001_bib363","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.23967","article-title":"miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization","volume":"74","author":"Moore","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib364","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2013.09.019","article-title":"MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"266","author":"Zhang","year":"2014","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib365","doi-asserted-by":"crossref","first-page":"8695","DOI":"10.3390\/ijms12128695","article-title":"Genetic association and altered gene expression of mir-155 in multiple sclerosis patients","volume":"12","author":"Paraboschi","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaut.2014.05.001_bib366","article-title":"Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients","author":"Katsushima","year":"2013","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jaut.2014.05.001_bib367","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.23386","article-title":"Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis","volume":"58","author":"Stanczyk","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.05.001_bib368","article-title":"Decreased expression of miR-146a and miR-155 contributes to an abnormal Treg phenotype in patients with rheumatoid arthritis","author":"Zhou","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2014.05.001_bib369","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/art.30281","article-title":"Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice","volume":"63","author":"Bluml","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.05.001_bib370","doi-asserted-by":"crossref","first-page":"e14302","DOI":"10.1371\/journal.pone.0014302","article-title":"Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus","volume":"5","author":"Dai","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2014.05.001_bib371","doi-asserted-by":"crossref","first-page":"924","DOI":"10.4049\/jimmunol.1002218","article-title":"Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu","volume":"186","author":"Divekar","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib372","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3899\/jrheum.100308","article-title":"Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus","volume":"37","author":"Wang","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaut.2014.05.001_bib373","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0033-1361088","article-title":"microRNA expressions in CD4+ and CD8+ T-cell subsets in autoimmune thyroid diseases","volume":"122","author":"Bernecker","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jaut.2014.05.001_bib374","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.autrev.2008.06.009","article-title":"Is autoimmunity a matter of sex?","volume":"7","author":"Lleo","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib375","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1586\/eci.11.42","article-title":"Thyroid physiology and autoimmunity in pregnancy and after delivery","volume":"7","author":"Gaberscek","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib376","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.steroids.2010.01.011","article-title":"Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy","volume":"75","author":"Maric","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.jaut.2014.05.001_bib377","doi-asserted-by":"crossref","first-page":"J177","DOI":"10.1016\/j.jaut.2011.11.007","article-title":"Gender differences in autoimmunity associated with exposure to environmental factors","volume":"38","author":"Pollard","year":"2012","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib378","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-230X-8-48","article-title":"Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density","volume":"8","author":"Klaus","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jaut.2014.05.001_bib379","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.4049\/jimmunol.175.8.5050","article-title":"Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses","volume":"175","author":"Delpy","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib380","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1515\/jpem-2012-0048","article-title":"Is vitamin D deficiency a feature of pediatric celiac disease?","volume":"25","author":"Villanueva","year":"2012","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jaut.2014.05.001_bib381","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-230X-11-136","article-title":"Clinical benefit of gluten-free diet in screen-detected older celiac disease patients","volume":"11","author":"Vilppula","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jaut.2014.05.001_bib382","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/08916930500288455","article-title":"Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus","volume":"38","author":"San-Pedro","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2014.05.001_bib383","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/me.2003-0281","article-title":"A\u00a0crucial role for the vitamin D receptor in experimental inflammatory bowel diseases","volume":"17","author":"Froicu","year":"2003","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jaut.2014.05.001_bib384","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2036.2010.04355.x","article-title":"Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study","volume":"32","author":"Jorgensen","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaut.2014.05.001_bib385","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.crohns.2011.08.002","article-title":"Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting","volume":"6","author":"Suibhne","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.jaut.2014.05.001_bib386","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ibd.22966","article-title":"Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis","volume":"19","author":"Xue","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaut.2014.05.001_bib387","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/ctg.2013.1","article-title":"Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients","volume":"4","author":"Yang","year":"2013","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jaut.2014.05.001_bib388","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","article-title":"High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis","volume":"44","author":"Nieves","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2014.05.001_bib389","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jaut.2014.05.001_bib390","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4158\/EP12152.RA","article-title":"Role of vitamin D in the onset, progression, and severity of multiple sclerosis","volume":"19","author":"Mesliniene","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jaut.2014.05.001_bib391","doi-asserted-by":"crossref","first-page":"e65487","DOI":"10.1371\/journal.pone.0065487","article-title":"Vitamin D3 receptor ( VDR ) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis","volume":"8","author":"Garcia-Martin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2014.05.001_bib392","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","article-title":"1, 25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis","volume":"93","author":"Cantorna","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2014.05.001_bib393","article-title":"The role of vitamin d in primary biliary cirrhosis: possible genetic and cell signaling mechanisms","volume":"2013","author":"LN","year":"2013","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jaut.2014.05.001_bib394","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.clinre.2013.05.016","article-title":"Vitamin D in autoimmune liver disease","volume":"37","author":"Smyk","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jaut.2014.05.001_bib395","doi-asserted-by":"crossref","first-page":"1036e9","DOI":"10.1016\/j.amjmed.2012.01.025","article-title":"Vitamin D, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritis","volume":"125","author":"Baker","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib396","first-page":"453","article-title":"Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients","volume":"17","author":"Andjelkovic","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaut.2014.05.001_bib397","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/art.11434","article-title":"Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study","volume":"50","author":"Merlino","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.05.001_bib398","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.humimm.2014.02.009","article-title":"Vitamin D receptor gene polymorphism as possible risk factor in rheumatoid arthritis and rheumatoid related osteoporosis","volume":"75","author":"Mosaad","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib399","first-page":"68","article-title":"1, 25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis","volume":"128","author":"Cantorna","year":"1998","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jaut.2014.05.001_bib400","article-title":"Vitamin D in \u201cearly\u201d primary Sjogren's syndrome: does it play a role in influencing disease phenotypes?","author":"Baldini","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaut.2014.05.001_bib401","article-title":"Comparison of plasma vitamin D levels in patients with Sjogren's syndrome and healthy subjects","author":"Erten","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaut.2014.05.001_bib402","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF02207671","article-title":"Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus","volume":"14","author":"Muller","year":"1995","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaut.2014.05.001_bib403","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00296-012-2537-7","article-title":"The predictive factors of low serum 25-hydroxyvitamin D and vitamin D deficiency in patients with systemic lupus erythematosus","volume":"33","author":"Sumethkul","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaut.2014.05.001_bib404","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000045635","article-title":"Vitamin-D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosus","volume":"85","author":"Ozaki","year":"2000","journal-title":"Nephron"},{"key":"10.1016\/j.jaut.2014.05.001_bib405","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1191\/0961203302lu143oa","article-title":"Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus","volume":"11","author":"Huang","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2014.05.001_bib406","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/08916939209150321","article-title":"1,25-Dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL\/l mice","volume":"12","author":"Lemire","year":"1992","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2014.05.001_bib407","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3177\/jnsv.36.21","article-title":"Prevention of immunological disorders in MRL\/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin D3","volume":"36","author":"Abe","year":"1990","journal-title":"J\u00a0Nutr Sci Vitaminol (Tokyo)"},{"key":"10.1016\/j.jaut.2014.05.001_bib408","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12020-012-9812-y","article-title":"Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis","volume":"43","author":"Feng","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.jaut.2014.05.001_bib409","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0090-1229(90)90005-B","article-title":"In\u00a0vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis","volume":"54","author":"Fournier","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jaut.2014.05.001_bib410","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/cmi.2010.73","article-title":"Vitamin D and autoimmune thyroid diseases","volume":"8","author":"Kivity","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib411","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3349\/ymj.2014.55.2.476","article-title":"Low serum vitamin D is associated with anti-thyroid peroxidase antibody in autoimmune thyroiditis","volume":"55","author":"Shin","year":"2014","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jaut.2014.05.001_bib412","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/thy.2009.0200","article-title":"Relative vitamin D insufficiency in Hashimoto's thyroiditis","volume":"21","author":"Tamer","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.jaut.2014.05.001_bib413","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12020-012-9789-6","article-title":"Serum vitamin D levels are decreased in patients without remission of Graves' disease","volume":"43","author":"Yasuda","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.jaut.2014.05.001_bib414","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2265.2008.03413.x","article-title":"Vitamin D receptor (VDR) gene polymorphisms and Graves' disease: a meta-analysis","volume":"70","author":"Zhou","year":"2009","journal-title":"Clin Endocrinol (Oxford)"},{"key":"10.1016\/j.jaut.2014.05.001_bib415","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.2337\/db10-1656","article-title":"Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes","volume":"60","author":"Cooper","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2014.05.001_bib416","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.4049\/jimmunol.1302350","article-title":"1,25-Dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice","volume":"192","author":"Ferreira","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib417","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(01)06580-1","article-title":"Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study","volume":"358","author":"Hypponen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2014.05.001_bib418","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2337\/dc11-0103","article-title":"Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes","volume":"34","author":"Kaur","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaut.2014.05.001_bib419","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2337\/diab.41.11.1491","article-title":"1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice","volume":"41","author":"Mathieu","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2014.05.001_bib420","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s00125-014-3181-4","article-title":"Prevalence of vitamin D deficiency in pre-type 1 diabetes and its association with disease progression","volume":"57","author":"Raab","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaut.2014.05.001_bib421","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9440(10)64516-6","article-title":"Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease","volume":"157","author":"Spieker","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2014.05.001_bib422","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000108113","article-title":"Plasma titers of antibodies against Epstein-Barr virus BZLF1 and risk of multiple sclerosis","volume":"28","author":"Massa","year":"2007","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jaut.2014.05.001_bib423","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.3390\/v4123701","article-title":"Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis-association and causation","volume":"4","author":"Lossius","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.jaut.2014.05.001_bib424","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","article-title":"Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain","volume":"204","author":"Serafini","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib425","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.21902","article-title":"Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Cavalcante","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaut.2014.05.001_bib426","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.yexmp.2012.09.012","article-title":"Serum markers of infections in patients with primary biliary cirrhosis: evidence of infection burden","volume":"93","author":"Shapira","year":"2012","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.jaut.2014.05.001_bib427","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI110127","article-title":"Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis","volume":"67","author":"Alspaugh","year":"1981","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2014.05.001_bib428","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.berh.2008.09.007","article-title":"Epstein-Barr virus in autoimmune diseases","volume":"22","author":"Toussirot","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jaut.2014.05.001_bib429","first-page":"49","article-title":"Epstein-Barr virus and the lacrimal gland pathology of Sjogren's syndrome","volume":"143","author":"Pflugfelder","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaut.2014.05.001_bib430","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12020-008-9068-8","article-title":"Herpes virus antibodies seroprevalence in children with autoimmune thyroid disease","volume":"33","author":"Thomas","year":"2008","journal-title":"Endocrine"},{"key":"10.1016\/j.jaut.2014.05.001_bib431","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.beem.2009.07.004","article-title":"Interferon induced thyroiditis","volume":"23","author":"Tomer","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jaut.2014.05.001_bib432","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jneuroim.2003.10.056","article-title":"Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis","volume":"148","author":"Magliozzi","year":"2004","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib433","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1371\/journal.pmed.0060001","article-title":"Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium","volume":"6","author":"Humby","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib434","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.0105-2896.2009.00861.x","article-title":"Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage\/remodeling","volume":"233","author":"Manzo","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaut.2014.05.001_bib435","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/1529-0131(200106)44:6<1438::AID-ART239>3.0.CO;2-Q","article-title":"Germinal center reaction in the joints of mice with collagen-induced arthritis: an animal model of lymphocyte activation and differentiation in arthritis joints","volume":"44","author":"Han","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.05.001_bib436","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/ar1900","article-title":"CXCL12 is displayed by rheumatoid endothelial cells through its basic amino-terminal motif on heparan sulfate proteoglycans","volume":"8","author":"Santiago","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaut.2014.05.001_bib437","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1126\/science.3726548","article-title":"A\u00a0distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium","volume":"233","author":"Jalkanen","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.jaut.2014.05.001_bib438","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.4049\/jimmunol.167.4.2361","article-title":"Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus","volume":"167","author":"Arce","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib439","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1172\/JCI200319301","article-title":"Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions","volume":"112","author":"Grammer","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2014.05.001_bib440","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10875-009-9325-5","article-title":"Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity","volume":"30","author":"Wong","year":"2010","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib441","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.4049\/jimmunol.170.12.6320","article-title":"Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases","volume":"170","author":"Armengol","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib442","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.4049\/jimmunol.178.9.5643","article-title":"Tertiary lymphoid structures in the pancreas promote selection of B lymphocytes in autoimmune diabetes","volume":"178","author":"Kendall","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib443","first-page":"3359","article-title":"Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of terti","volume":"185","author":"Astorri","year":"2010","journal-title":"J\u00a0Immunol (Baltimore, Md: 1950)"},{"key":"10.1016\/j.jaut.2014.05.001_bib444","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12026-014-8500-9","article-title":"CCR7 directs the recruitment of T cells into inflamed pancreatic islets of nonobese diabetic (NOD) mice","volume":"58","author":"Shan","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaut.2014.05.001_bib445","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-230X-12-159","article-title":"Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing\u2013a cohort study","volume":"12","author":"Tack","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jaut.2014.05.001_bib446","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1042\/CS20130478","article-title":"Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients","volume":"126","author":"Caruso","year":"2014","journal-title":"Clin Sci (London)"},{"key":"10.1016\/j.jaut.2014.05.001_bib447","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2249.2011.04510.x","article-title":"Up-regulation of small intestinal interleukin-17 immunity in untreated coeliac disease but not in potential coeliac disease or in type 1 diabetes","volume":"167","author":"Lahdenpera","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib448","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2014.05.001_bib449","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1053\/j.gastro.2010.12.002","article-title":"Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases","volume":"140","author":"Hovhannisyan","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2014.05.001_bib450","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2249.2010.04093.x","article-title":"The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease","volume":"160","author":"Sugihara","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib451","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.MIB.0000218764.06959.91","article-title":"Critical role of IL-17 receptor signaling in acute TNBS-induced colitis","volume":"12","author":"Zhang","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaut.2014.05.001_bib452","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/135245859900500206","article-title":"Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis","volume":"5","author":"Matusevicius","year":"1999","journal-title":"Mult Scler"},{"key":"10.1016\/j.jaut.2014.05.001_bib453","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm0502-500","article-title":"Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis","volume":"8","author":"Lock","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib454","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2014.05.001_bib455","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.immuni.2011.10.015","article-title":"Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation","volume":"35","author":"Peters","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2014.05.001_bib456","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/mus.22070","article-title":"Increased serum interleukin-17 levels in patients with myasthenia gravis","volume":"44","author":"Roche","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jaut.2014.05.001_bib457","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2008.11.001","article-title":"Hepatic IL-17 responses in human and murine primary biliary cirrhosis","volume":"32","author":"Lan","year":"2009","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2014.05.001_bib458","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cyto.2013.07.005","article-title":"Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosis","volume":"64","author":"Qian","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2014.05.001_bib459","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","article-title":"Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population","volume":"156","author":"Rong","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib460","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hep.26979","article-title":"IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: Implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2014.05.001_bib461","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","article-title":"Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium","volume":"42","author":"Chabaud","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.05.001_bib462","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1756-185X.2011.01673.x","article-title":"The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis","volume":"15","author":"Liu","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaut.2014.05.001_bib463","first-page":"73","article-title":"IL-17 patterns in synovium, serum and synovial fluid from treatment-naive, early rheumatoid arthritis patients","volume":"53","author":"Rosu","year":"2012","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.jaut.2014.05.001_bib464","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib465","first-page":"970","article-title":"Salivary cytokine profiles in primary Sjogren's syndrome differ from those in non-Sjogren sicca in terms of TNF-alpha levels and Th-1\/Th-2 ratios","volume":"29","author":"Kang","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaut.2014.05.001_bib466","article-title":"Th17 cells play a critical role in the development of experimental Sjogren's syndrome","author":"Lin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2014.05.001_bib467","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clim.2008.01.019","article-title":"Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity","volume":"127","author":"Wong","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib468","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ni.1741","article-title":"Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus","volume":"10","author":"Doreau","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib469","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2009-1719","article-title":"Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis","volume":"95","author":"Figueroa-Vega","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jaut.2014.05.001_bib470","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.clim.2013.10.001","article-title":"Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patients","volume":"149","author":"Li","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib471","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-3083.2010.02425.x","article-title":"Differentiation imbalance of Th1\/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis","volume":"72","author":"Shi","year":"2010","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib472","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.4049\/jimmunol.0900576","article-title":"Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells","volume":"183","author":"Bradshaw","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib473","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2337\/db08-1113","article-title":"Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice","volume":"58","author":"Emamaullee","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jaut.2014.05.001_bib474","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2567.2009.03166.x","article-title":"Interleukin-17-producing gammadelta+ T cells protect NOD mice from type 1 diabetes through a mechanism involving transforming growth factor-beta","volume":"129","author":"Han","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2014.05.001_bib475","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.4049\/jimmunol.0902822","article-title":"Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes","volume":"184","author":"Nikoopour","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib476","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/ni.1774","article-title":"Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in\u00a0vivo","volume":"10","author":"Zhou","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaut.2014.05.001_bib477","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/art.24501","article-title":"Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis","volume":"60","author":"Campbell","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2014.05.001_bib478","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.4049\/jimmunol.0902434","article-title":"An autoimmune response to odorant binding protein 1a is associated with dry eye in the Aire-deficient mouse","volume":"184","author":"DeVoss","year":"2010","journal-title":"J\u00a0Immunol"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841114000900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:09:28Z","timestamp":1760256568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841114000900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":478,"alternative-id":["S0896841114000900"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2014.05.001","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myasthenia Gravis: Paradox versus paradigm in autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2014.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}